The life-sciences sector is in rude health!

Il y a 5 years
life-sciences

It’s not just that companies engaged in the sector are doing very well, but even better, more investment is expected!

 

The talk is all of growth and expansion of spin-offs. The calibre of our researchers (which is common knowledge), together with the policy of shrewd economic development in Wallonia, continues to manifest itself in the positive results of their combined efforts. Among the good news, we might highlight the following:

  • Uteron Pharma, who is based in Liège, have sewn up a new increase in capital concerning a sum of 14 million Euros. The funds raised should enable it to continue financing its growth as specialists in the field of female health.
  • Promethera, a UCL spin-off, is raising 23.6 million thanks to the backing of private investors and Wallonia Region.
  • The spin-off Bone Therapeutics, which has posted up capital of close to 15 million Euros, will shortly be building its premises at Aéropole in Charleroi to meet its particular R&D and production needs, also its prospects of expansion.

 
For more info, just get in touch with our Life-sciences expert:

Philippe JANSSENS – (+32) 81 33 28 54


Your tools :

  • Bookmark this page
  • Print this page